Pancreatic Cancer Research

ResearcherHainan General HospitalActive in the last 2 years

Shizong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6312-0358; OpenAlex author ID A5102965841. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Cancer-associated fibroblast-derived circKLHL24 drives perineural invasion in pancreatic cancer via dual regulation of the sec31a-CXCL12 axis. Co-author DOI 10.1186/s13046-025-03489-2↗
  2. miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer. Co-author DOI 10.1007/s13577-020-00395-x↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tianhao Huang · 1 shared paper, 2025 · strength 0.22
  2. Tingting Li · 1 shared paper, 2025 · strength 0.22
  3. Guolin Li · 1 shared paper, 2025 · strength 0.22
  4. Chengyuan Hu · 1 shared paper, 2025 · strength 0.22
  5. Huimou Chen · 1 shared paper, 2025 · strength 0.22
  6. Shangyou Zheng · 1 shared paper, 2025 · strength 0.22
  7. Rufu Chen · 1 shared paper, 2025 · strength 0.22
  8. Rihua He · 1 shared paper, 2025 · strength 0.22
  9. Lin Wang · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.